This website provides educational information about medicines and active ingredients. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Blog

METHOCARBAMOL (Robaxin): What is used for?

[toc] What is Methocarbamol? Methocarbamol (Metocarbamol) is a drug used to treat muscle spasms. The brand names of Methocarbamol in the United States are: Robaxin, Robaxin-750. Mechanism of action (MOA) of Methocarbamol Muscle relaxant...

Educational content Use this article as a starting point for understanding the topic.
Check with a professional Ask a doctor or pharmacist before changing any medicine.
Safety first Side effects, interactions and risks depend on each person.
Medical disclaimer

This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.

[toc]

What is Methocarbamol?

Methocarbamol (Metocarbamol) is a drug used to treat muscle spasms.
The brand names of Methocarbamol in the United States are: Robaxin, Robaxin-750.

Mechanism of action (MOA) of Methocarbamol

Muscle relaxant of central action, whose action could be due to a general depressant effect on the CNS. It blocks contracturant and painful reflexes at the level of the spinal cord synapses without affecting the muscle or the motor plaque.

Therapeutic indications, uses and benefits of Methocarbamol

Short-term symptomatic treatment of painful muscle spasms in acute musculoskeletal disorders.

Metocarbamol dosage

Oral:
Adults: 1 g-1.5 g/6 h, in severe cases a higher dose is necessary, maximum recommended dose: 8 g/day for the first 48-72 h. In the elderly: 500 mg/6 h.

Method of administration of Methocarbamol

Oral use.

Take the tablets with a glass of water.

Contraindications of Methocarbamol

  • Hypersensitivity to this active ingredient.
  • Coma or precoma states.
  • Known cerebral pathology.
  • History of seizures or epilepsy.
  • Myasthenia gravis.

Warnings and precautions with Methocarbamol

  • Liver failure.
  • Kidney failure.
  • Children < 18 years lack of data on safety and efficacy.

Liver failure

Caution.

Kidney failure

Caution.

Interactions with Metocarbamol

  • Increases the effects of: CNS depressants and stimulants including alcohol, barbiturates, anesthetics, and appetite suppressants.
  • Enhances effects of: anticholinergics such as atropine and some psychotropicPosology
    Inhibits the effect of: pyridoestigmine bromide
  • Lob: interferes with the analytical valuations of 5-hydroxyindolacetic ac.

Pregnancy and Methocarbamol

Metocarbamol is not recommended for use by pregnant women or women considering becoming pregnant, particularly in the early stages of pregnancy, unless the potential benefits outweigh the possible risks of its use.

Breastfeeding

Metocarbamol and/or its metabolites have been detected in milk in dogs, however, it is not known whether metocarbamol or its metabolites are excreted by human breast milk.

Therefore, caution should be exercised when administering to breastfeeding women.

Effects on driving ability

Metocarbamol may cause drowsiness, so patients should not drive vehicles or operate machines unless they are satisfied that their mental capacity remains unchanged, especially if other medications that may also cause drowsiness are administered concomitantly.

Adverse reactions and side effects of Metocarbamol

Leucopenia; bradycardia, flushing, hypotension, syncope; diplopia, blurred vision, nystagmus; dyspepsia, nausea and vomiting, dysgeusia.

Angioneurotic edema, anaphylactic reaction, fever, headache, conjunctivitis accompanied by nasal congestion, metallic taste; jaundice (including cholestatic jaundice); nervousness, anxiety, tremor, amnesia, confusion, dizziness or lightheadedness, vertigo, drowsiness, insomnia, mild muscle incoordination, seizures (including grand mal); itching, rash, hives.

⭐⭐⭐⭐⭐ VIDEO OF METHOCARBAMOL (DRUG)

Source: The content of this active ingredient has been written taking into account the clinical and molecular information of all medicines authorised and marketed in the United States under the Unique Ingredient Identifier (UNII) by the Substance Registration System (SRS) of the Food and Drug Administration (FDA) and the United States Pharmacopeia (USP).

In order to know in detail the information authorized by the FDA for each drug, you should consult the corresponding medication guide authorized by the FDA.

Resources:

UNII: 125OD7737X
ChemIDplus
DrugPortal
PubChem CID: 4107
NCI Thesaurus: C29252

Editorial note Active Ingredients Online Editorial Team This article is prepared as educational medicine information for general readers. It is written to support understanding of active ingredients, medicine uses, possible side effects, precautions and safety-related questions.
Published: June 13, 2019 Updated: August 2, 2019 Educational content

Medical disclaimer

This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.

Sources and verification

Medicine information can change by country, product formulation and official safety updates. For personal decisions, verify details with official medicine information and a qualified healthcare professional. These official resources can help readers check medicine safety information:

To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.

Final note

Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.

See also...
Ask a Doctor Online medical questions